Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Recurso digital |
| Sprache: | |
| Veröffentlicht: |
Zenodo
2025
|
| Online-Zugang: | https://doi.org/10.5281/zenodo.14964695 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Inhaltsangabe:
- <p><strong><span>The purpose of our study </span></strong><span>was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.</span></p>